「先导照射」分割伴早期治疗间歇在早期非小细胞肺癌中理论上优于连续工作日分割方案
该研究基于资源竞争与细胞周期依赖性放射敏感性的肿瘤剂量-反应模型,对早期NSCLC的多种分割方案(18Gy×3、12Gy×4、10Gy×5、7.5Gy×8、5Gy×12、4Gy×15)数学优化分次间隔,发现最优方案均倾向「先导照射」后2周间歇以促进肿瘤再氧合,相比连续工作日分割预测局部失败绝对降低4.6%-7.4%(18Gy×3因已最优除外),并可在等TCP下降低BED3。
要点
- 模型预测最优分割均含「先导照射」后约2周间歇,以利肿瘤再氧合。
- 优化方案较连续工作日分割预测局部失败绝对降低4.6%-7.4%,18Gy×3除外。
- 在等TCP下优化方案可降低BED3,最短方案18Gy×3降低94.6Gy最显著。
核心结论
- 经校验的模拟模型明确支持非标准「先导照射」分割,以降低缺氧所致放射抵抗的影响。
- 作者指出「先导照射」分割超出既往临床经验,需临床研究才能最终检验。
研究设计与样本
- 基于资源竞争与细胞周期依赖性放射敏感性的肿瘤剂量-反应模型,该模型此前已准确预测早期NSCLC队列的局部失败率。
- 模型对18Gy×3、12Gy×4、10Gy×5、7.5Gy×8、5Gy×12、4Gy×15分割方案数学确定非均匀分次间隔,以在相似正常组织毒性风险(等BED3/等NTCP)下最小化局部失败。
- 随后用优化方案在维持稳定局部失败(TCP)的同时降低毒性风险(BED3)。
主要发现
- 最优方案一致倾向「先导照射」分次后2周间歇,允许肿瘤再氧合。
- 增加或减少假定基线缺氧可使最优间歇延长或缩短最多一周。
- 7.5Gy及以上分次大小需要单次先导照射,更小分次需要额外一或两次分次以实现完全再氧合。
- 优化方案对比连续工作日分割,预测局部失败绝对降低4.6%-7.4%,但18Gy×3因局部失败率已最优而除外。
- 先导照射方案可在等TCP下降低BED3,最短方案改善最大(18Gy×3降低94.6Gy)。
关键数值与推荐
- 分割方案包括18Gy×3、12Gy×4、10Gy×5、7.5Gy×8、5Gy×12、4Gy×15。
- 优化方案对比连续工作日分割预测局部失败绝对降低4.6%-7.4%,18Gy×3除外。
- 等TCP下BED3降低,18Gy×3降低94.6Gy为最大改善。
临床怎么用
- 原文未据此给出推荐。
局限性
- 先导照射分割超出既往临床经验,因此需要临床研究才能最终检验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Radiotherapy is traditionally given in equally spaced weekday fractions. We hypothesize that heterogeneous interfraction intervals can increase radiosensitivity via reoxygenation. Through modeling, we investigate whether this minimizes local failures and toxicity for early-stage non-small cell lung cancer (NSCLC). METHODS: Previously, a tumor dose-response model based on resource competition and cell-cycle-dependent radiosensitivity accurately predicted local failure rates for early-stage NSCLC cohorts. Here, the model mathematically determined non-uniform inter-fraction intervals minimizing local failures at similar normal tissue toxicity risk, i.e., iso-BED3 (iso-NTCP) for fractionation schemes 18Gyx3, 12Gyx4, 10Gyx5, 7.5Gyx8, 5Gyx12, 4Gyx15. Next, we used these optimized schedules to reduce toxicity risk (BED3) while maintaining stable local failures (TCP). RESULTS: Optimal schedules consistently favored a "primer shot" fraction followed by a 2-week break, allowing tumor reoxygenation. Increasing or decreasing the assumed baseline hypoxia extended or shortened this optimal break by up to one week. Fraction sizes of 7.5 Gy and up required a single primer shot, while smaller fractions needed one or two extra fractions for full reoxygenation. The optimized schedules, versus consecutive weekday fractionation, predicted absolute LF reductions of 4.6%-7.4%, except for the already optimal LF rate seen for 18Gyx3. Primer shot schedules could also reduce BED3 at iso-TCP with the biggest improvements for the shortest schedules (94.6Gy reduction for 18Gyx3). CONCLUSION: A validated simulation model clearly supports non-standard "primer shot" fractionation, reducing the impact of hypoxia-induced radioresistance. A limitation of this study is that primer-shot fractionation is outside prior clinical experience and therefore will require clinical studies for definitive testing.
引用
- Gouw ZAR, Jeong J, Rimner A, et al. "Primer shot" fractionation with an early treatment break is theoretically superior to consecutive weekday fractionation schemes for early-stage non-small cell lung cancer. Radiother Oncol. 2023. PMID: 37972733. doi:10.1016/j.radonc.2023.110006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。